News and Commentary

Top FDA Officials Reject Call To Halve COVID-19 Doses In Order To Distribute More Widely

"The available data continue to support the use of two specified doses"

Joseph Curl
Top FDA Officials Reject Call To Halve COVID-19 Doses In Order To Distribute More Widely
Taechit Taechamanodom / Getty Images

Two top officials with the Food and Drug Administration (FDA) have announced they oppose a plan to cut the dosage of a COVID-19 vaccine in half, saying the move is “premature.”

On Sunday, Moncef Slaoui, chief scientific adviser of Operation Warp Speed, a vaccine program established by President Donald Trump, said half a dose of the Moderna vaccine is just as effective as a full dose. “We know that for the Moderna vaccine, giving half of the dose to people between the ages of 18 and 55, two doses, half the dose, which means exactly achieving the objective of immunizing double the number of people with the doses we have,” Slaoui said on CBS’ “Face the Nation.”

Got a tip worth investigating?

Your information could be the missing piece to an important story. Submit your tip today and make a difference.

Submit Tip